Trends in targeting Bcl-2 anti-apoptotic proteins for cancer treatment

Z Zhang, L Bai, L Hou, H Deng, S Luan, D Liu… - European Journal of …, 2022 - Elsevier
Apoptosis is the major mode of programmed cell death, which conduces to maintain tissue
homeostasis, clearance of abnormal cells and development of organisms. Over the past two …

Bcl-2 family members as molecular targets in cancer therapy

I Marzo, J Naval - Biochemical pharmacology, 2008 - Elsevier
Escape from apoptosis is often a hallmark of cancer cells, and is associated to
chemotherapy resistance or tumor relapse. Proteins from the Bcl-2 family are the key …

Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells

SME Oxford, CL Dallman, PWM Johnson… - Current medicinal …, 2004 - ingentaconnect.com
Apoptosis (or programmed cell death) is a genetically controlled “cell suicide” pathway
which plays an essential role in deleting excess, unwanted or damaged cells during …

Targeting anti-apoptotic BCL-2 family proteins for cancer treatment

X Zhang, X Liu, D Zhou, G Zheng - Future Medicinal Chemistry, 2020 - Future Science
Apoptosis, also known as programmed cell death, contributes to cellular homeostasis,
normal development and clearance of abnormal cells [1]. Dysregulation of apoptotic …

Drugs targeting Bcl-2 family members as an emerging strategy in cancer

B Leber, F Geng, J Kale, DW Andrews - Expert reviews in molecular …, 2010 - cambridge.org
Inhibiting apoptosis is widely accepted as a necessary step in the transition from normal to
cancer cells, and most cancer therapies exert their effects by indirectly reversing this …

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

N Bajwa, C Liao… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: The B-cell lymphoma-2 (Bcl-2) family of proteins is central to the regulation of
apoptosis, which is vital for proper tissue development and cellular homeostasis. Anti …

Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer

GC Shore, J Viallet - ASH Education Program Book, 2005 - ashpublications.org
Members of the BCL-2 family of proteins regulate and execute many cell intrinsic apoptosis
pathways, including those arising from dysregulated expression of cellular oncogenes …

Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer

B Weyhenmeyer, AC Murphy, JHM Prehn… - Experimental …, 2012 - dspace.nbuv.gov.ua
Most cells express a variety of both anti-apoptotic and pro-apoptotic Bcl-2 proteins and the
interaction within this family dictates whether a cell survives or dies. The dysregulation of the …

Finally, an apoptosis-targeting therapeutic for cancer

CM Croce, JC Reed - Cancer research, 2016 - AACR
Resistance to cell death represents one of the hallmarks of cancer. Various genetic and
epigenetic changes in malignant cells afford cytoprotection in the face of genomic instability …

Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity

EJ Hennessy - Bioorganic & medicinal chemistry letters, 2016 - Elsevier
The induction of apoptosis in tumor cells represents a promising approach to the treatment
of cancer. Accordingly, compounds that interact with the Bcl-2 family of proteins, which are …